Efficacy and safety of norepinephrine combined with albumin versus terlipressin combined with albumin in treatment of type 1 hepatorenal syndrome: A Meta-analysis
Objective To systematically review the efficacy and safety of norepinephrine combined with albumin versus terlipressin combined with albumin in the treatment of type 1 hepatorenal syndrome (HRS1). Methods PubMed, EMBASE, Medline, Cochrane Library, CNKI, Wanfang Data, and VIP were searched for compar...
Main Author: | QIN Yanxin |
---|---|
Format: | Article |
Language: | zho |
Published: |
Editorial Department of Journal of Clinical Hepatology
2019-10-01
|
Series: | Linchuang Gandanbing Zazhi |
Online Access: | http://www.lcgdbzz.org/qk_content.asp?id=10255 |
Similar Items
-
Therapeutic effect of terlipressin combined with albumin in 24 patients with hepatorenal syndrome
by: CHEN Si
Published: (2014-08-01) -
Low doses of terlipressin and albumin in the type I hepatorenal syndrome
by: Davide Pulvirenti, et al.
Published: (2013-05-01) -
Terlipressin versus norepinephrine in the treatment of hepatorenal syndrome: a systematic review and meta-analysis.
by: Antonio Paulo Nassar Junior, et al.
Published: (2014-01-01) -
Reversal of hepatorenal syndrome in cirrhotic patients with terlipressin plus albumin. First experience in Mexico
by: Linda E. Muñoz, et al.
Published: (2009-07-01) -
Noradrenaline or terlipressin for hepatorenal syndrome?
by: Pilar Celis, et al.
Published: (2015-08-01)